Physician profile
Mujtaba A Khan
NPI 1629047857
$6,430.53
in general payments reported to CMS, 2019-2025
19 companies · $208 in 2025
The $208 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $341 · 2020: $1,500 · 2021: $407 · 2022: $416 · 2023: $136 · 2024: $3,423 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,884 · Food and Beverage: $1,883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,883.99 |
| Food and Beverage | $1,882.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,140.16 | 2023-2025 | Watchman Flx |
| Medtronic Vascular, INC. | $1,552.38 | 2019-2020 | |
| Medtronic, INC. | $1,263.94 | 2024-2025 | Azure Xt Dr Mri Surescan |
| Novartis Pharmaceuticals Corporation | $272.71 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $228.98 | 2019-2023 | Farxiga |
| Amgen INC. | $152.56 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $149.98 | 2021-2023 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $146.09 | 2020-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $142.45 | 2019-2020 | |
| Biosense Webster, INC. | $91.22 | 2021 | |
| Merck Sharp & Dohme LLC | $65.21 | 2022-2023 | Verquvo |
| Pfizer INC. | $57.14 | 2021-2022 | |
| Bridgebio Pharma, INC. | $34.50 | 2025 | Attruby |
| Abbott Laboratories | $30.66 | 2022-2025 | Viewmate |
| Amarin Pharma, INC. | $26.63 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $26.04 | 2021 | |
| Biotronik INC. | $19.63 | 2025 | Biomonitor |
| Janssen Pharmaceuticals, INC | $18.31 | 2022 | |
| Astellas Pharma US INC | $11.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mujtaba Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.